Plasma is already used in other applications, including as a method to limit bacteria growth on meat in the food industry.
In 2000, Shi created a cold atmospheric plasma device for surface modification as part of his research on nanoparticles. That research and expertise informed the concept to utilize plasma on viruses.
Shi is partnering with Paul Spearman, M.D., director of the Division of Infectious Diseases at Cincinnati Children’s Hospital Medical Center. The prototype device is now awaiting efficacy testing at Cincinnati Children’s.
The idea was also supported through UC’s Venture Lab business pre-accelerator, which provided Shi the opportunity to learn how to build the concept into a marketable product. Once proven successful in inactivating coronavirus, Shi said the plasma treatment would be ideal for use in public spaces, particularly in the travel industry, such as on trains, airplanes, rental cars and hotels.
Shi, who first joined UC in 1995, was recently named a 2020 Fellow of ASM International, a professional organization for materials engineers and scientists. He was recognized for pioneering contributions to superconducting materials, magnetism and magnetic materials and novel nanostructures for photonic, biomedical and drug delivery applications.
